#USA #Singapore #QDX #Giuseppe Barca #Dirac Medal

Celebrating Innovation in Computational Chemistry

In a remarkable achievement, QDX has extended its congratulations to Co-Founder and Head of Research, Associate Professor Giuseppe Barca, who has been awarded the esteemed 2025 Dirac Medal. This accolade is recognized globally as the highest honor for early-career researchers specializing in theoretical and computational chemistry, underscoring Barca's significant contributions to the field.

A Pioneering Researcher

Presented by the World Association of Theoretical and Computational Chemists (WATOC), the Dirac Medal is awarded to scientists under the age of 40 who have made exceptional strides in their research areas. A/Prof. Barca has been acknowledged for his groundbreaking innovations in the realms of quantum algorithms and high-performance computing. His work has not only pushed the boundaries of molecular simulation but has also accelerated advancements in drug discovery processes.

In the words of QDX's CEO, Loong Wang, "This is a phenomenal and well-deserved honor for Giuseppe. His research continues to redefine what’s possible in computational chemistry. This award not only celebrates his individual achievement but also reinforces the bold science that drives QDX".

Advancing Drug Discovery

Alongside his responsibilities at QDX, A/Prof. Barca also oversees the Barca Lab at both the Australian National University and the University of Melbourne. Here, he innovates fast and scalable quantum chemistry methods and algorithms tailored for next-generation computing platforms. His breakthroughs serve as the backbone of Rush, QDX's proprietary AI-quantum platform, designed to deliver high-precision molecular modeling on a cloud scale.

As QDX forges ahead in the domain of drug discovery, utilizing advanced computational tools, A/Prof. Barca's insights and leadership remain pivotal. His vision aligns with the company’s mission, which is to expedite the discovery of new and effective therapies for various diseases.

About QDX

Founded by a team of experts in life science, computational chemistry, and high-performance computing, QDX is dedicated to revolutionizing drug discovery through the use of high-performance quantum simulations. Collaborating with global partners, the company aims to devise innovative solutions for complex diseases, thereby fundamentally transforming the landscape of drug development. Its flagship platform, Rush, empowers biotech innovators to perform rapid and cost-effective molecular modeling without requiring specialized installations or proprietary hardware.

By continuing to champion research and innovation, QDX, under A/Prof. Barca’s guidance, is set to redefine the capabilities and effectiveness of drug discovery in the modern era.